Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000209:etiology; D004274:DNA, Recombinant; D004341:Drug Evaluation; D005221:Fatigue / Q000209:etiology; D005334:Fever / Q000209:etiology; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000628:therapy*; D008875:Middle Aged
D004274:DNA, Recombinant; D007370:Interferon Type I